CD56 Blocking Peptide for STJ500479 peptide (STJ505286)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 800-847 on human neural cell adhesion molecule 1.
General Information
| Short Description | CD56 Blocking Peptide for STJ500479 is synthetically produced from the 800-847 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 800-847 on human neural cell adhesion molecule 1. |
| Immunogen Region | 800-847 |
| Specificity | This blocking peptide is recommended for use in combination with CD56 antibody, STJ500479 |
Additional Info
| Background | Extracellular matrix and cell adhesion protein that plays a role in nervous system development and in synaptic plasticity. Both soluble and membranous forms promote neurite outgrowth of cerebellar and hippocampal neurons and suppress neuronal cell death. Plays a role in neuronal positioning of pyramidal neurons and in regulation of both the number of interneurons and the efficacy of GABAergic synapses. May play a role in regulating cell migration in nerve regeneration and cortical development. Potentiates integrin-dependent cell migration towards extracellular matrix proteins. Recruits ANK3 to the plasma membrane (By similarity). |
Information sourced from Uniprot.org